Takeda's Zika vaccine gets U.S. FDA's 'fast track' status
(Reuters) - Japan's Takeda Pharmaceutical Co Ltd said on Monday the U.S. Food and Drug Administration had granted 'fast track' status to its vaccine for the mosquito-borne Zika virus, which erupted as a major public hazard in Brazil three years ago.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Brazil Health | Food and Drug Administration (FDA) | Health | Japan Health | Vaccines | Zika Virus